CSIMarket
 


Ispecimen inc   (ISPC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Ispecimen Inc 's Working Capital Ratio

ISPC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the forth quarter 2023, Working Capital Ratio fell to 1.37 a new company low.

Within Medical Laboratories industry 21 other companies have achieved higher Working Capital Ratio than Ispecimen Inc in forth quarter 2023. While Working Capital Ratio total ranking in the forth quarter 2023 has deteriorated compared to the prior quarter from 501 to 1785.

Explain Working Capital Ratio
How much in Current Assets ISPC´s has?
What is the value of ISPC´s Current Liabilities?


ISPC Working Capital Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Change 41.29 % 24.13 % 35.59 % 81.11 % 70.87 %
Y / Y Current Assets Change -57.99 % -62.34 % -59.51 % -47.07 % -40.28 %
Working Capital Ratio MRQ 1.37 2.59 3.99 4.31 4.6
ISPC's Total Ranking # 1785 # 501 # 251 # 687 # 922
Seq. Current Liabilities Change 71.99 % 27.81 % -25.77 % -13.4 % 51.1 %
Seq. Current Assets Change -9.43 % -16.93 % -31.16 % -18.88 % -18.82 %



Working Capital Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 22
Healthcare Sector # 403
Overall Market # 1785


Working Capital Ratio Statistics
High Average Low
14.73 6.96 1.37
(Mar 31 2022)   (Dec 31 2023)




Financial Statements
Ispecimen Inc 's Current Liabilities $ 6 Millions Visit ISPC's Balance sheet
Ispecimen Inc 's Current Assets $ 8 Millions Visit ISPC's Balance sheet
Source of ISPC's Sales Visit ISPC's Sales by Geography


Cumulative Ispecimen Inc 's Working Capital Ratio

ISPC's Working Capital Ratio for the trailling 12 Months

ISPC Working Capital Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities TTM Growth 41.29 % 24.13 % 35.59 % 81.11 % 70.87 %
Y / Y Current Assets TTM Growth -57.99 % -62.34 % -59.51 % -47.07 % -40.28 %
Working Capital Ratio TTM 2.77 3.91 5.22 6.77 9.04
Total Ranking TTM # 1371 # 1373 # 3176 # 687 # 3046
Seq. Current Liabilities TTM Growth 71.99 % 27.81 % -25.77 % -13.4 % 51.1 %
Seq. Current Assets TTM Growth -9.43 % -16.93 % -31.16 % -18.88 % -18.82 %


On the trailing twelve months basis Due to jump in Current Liabilities in the IV Quarter 2023 to $6.05 millions, cumulative Working Capital Ratio decreased to 2.77 below the Ispecimen Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 15 other companies have achieved higher Working Capital Ratio than Ispecimen Inc . While Working Capital Ratio overall ranking has improved so far to 1371, from total ranking during the twelve months ending third quarter 2023 at 1373.

Explain Working Capital Ratio
How much in Current Assets ISPC´s has?
What is the value of ISPC´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 16
Healthcare Sector # 336
Within the Market # 1371


trailing twelve months Working Capital Ratio Statistics
High Average Low
12.16 7.41 2.72
(Sep 30 2022)   (Dec 31 2023)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2023, within Medical Laboratories Industry Working Capital RatioDec 31 2023 MRQ Current AssetsDec 31 2023 MRQ Current Liabilities
Incyte Corporation  3.75 $ 4,645.402  Millions$ 1,240.379  Millions
Enzo Biochem Inc  3.31 $ 80.920  Millions$ 24.421  Millions
Inotiv Inc   3.05 $ 190.688  Millions$ 62.563  Millions
Sera Prognostics Inc   2.51 $ 61.344  Millions$ 24.443  Millions
Exact Sciences Corporation  2.46 $ 1,194.369  Millions$ 485.322  Millions
Fortrea Holdings Inc   2.43 $ 1,253.100  Millions$ 515.000  Millions
Charles River Laboratories International inc   1.98 $ 1,608.662  Millions$ 813.262  Millions
Medpace Holdings Inc   1.63 $ 593.828  Millions$ 365.271  Millions
Quest Diagnostics Inc  1.43 $ 2,372.000  Millions$ 1,662.000  Millions
Ispecimen inc   1.37 $ 8.266  Millions$ 6.049  Millions
Icon Plc  1.21 $ 3,411.470  Millions$ 2,825.608  Millions
Iqvia Holdings Inc   1.19 $ 5,596.000  Millions$ 4,692.000  Millions
Koninklijke Philips Nv  1.17 $ 11,132.800  Millions$ 9,517.760  Millions
Laboratory Corporation Of America Holdings  1.17 $ 3,765.400  Millions$ 3,225.200  Millions
Ge Healthcare Technologies Inc   1.05 $ 9,410.000  Millions$ 8,981.000  Millions
National Research Corporation  0.67 $ 24.360  Millions$ 36.203  Millions

Date modified: 2024-03-13T23:05:05+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com